Financial policies in Russian compulsory medical insurance: regional strategies for access to healthcare services in oncology
https://doi.org/10.47093/2713-069X.2022.3.2.38-45
Abstract
Forming a key source of the regulatory framework for the provision of medical care to the population since 2022, Russian National Guidelines have given rise to a complex set of legal relations in the financial and economic activities of medical organizations and constituent entities of the Russian Federation, associated with ensuring the necessary amount of medical care. This article analyzes the scope of opportunities for a regional health authority in providing the most effective system for financing oncological care in the region and analyzes examples of effective adaptation of the regional financing system to the requirements of clinical guidelines.
About the Authors
A. I. SapaniukRussian Federation
Alexey I. Sapaniuk – Cand. of Sci. (Medicine)
Stroiteley ave., 1, Krasnogorsk, 143407
K. V. Ljadov
Russian Federation
Konstantin V. Ljadov – Dr. of Sci. (Medicine), Professor, Academician of the RAS, Chief Physician; Professor, Sports and Rehabilitation Medicine Department
Panfilova str., 21/2, Khimki, 141407
Trubetskaya str., 8/2, Moscow, 119991
V. G. Polushkin
Russian Federation
Vitaly G. Polushkin – Deputy chief Physician; Scientific officer of Institute of Leadership and Health Care Management
Panfilova str., 21/2, Khimki, 141407
Trubetskaya str., 8/2, Moscow, 119991
A. V. Alatortsev
Russian Federation
Alexey V. Alatortsev – Deputy Director
Butyrskaya str., 46/1, Moscow, 127015
O. B. Otdelnova
Russian Federation
Olga B. Otdelnova – Division head, Department of Oncology
Stroiteley ave., 1, Krasnogorsk, 143407
References
1. Actual issues of organization and payment of examinations for diagnosis of cancer in 2021: expert opinion. Medical technologies. Assessment and Choice. 2021; 2(43): 32–37 (In Russian). https://doi.org/10.17116/medtech20214302132
2. Kuranov V.G. Legal status of clinical recommendations in the medical law of the Russian Federation. Medical Law: Theory and Practice. 2019; 5(2(10)): 20–27 (In Russian).
3. Kislov N.V., Nesterov P.V., Delomogov S.B. Practical aspects of the application of clinical recommendations in oncology. Medical technologies. Assessment and Choice. 2020; 2(40): 43–49 (In Russian). https://doi.org/10.17116/medtech20204002143
4. Tsukanov A.S., Shelygin Yu. A., Shubin V.P. Microsatellite instability in colorectal cancer (literature review). Coloproctology. 2017; 2(60):100–104 (In Russian).
5. Ed. by Kaprin A.D., Starinsky V.V., Shakhzadova A.O. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Moscow: P.A. Herzen Moscow State Medical Research Institute − branch of the NMIC of Radiology, 2021. Fig. 252 p (In Russian).
6. Bagrova S.G., Kopp M.V., Kutukova S.I., et al. The use of osteomodifying agents for the prevention and treatment of bone tissue pathology in malignant neoplasms. Malignant Tumoursis. 2019; 9(3S2): 576–584 (In Russian). https://doi.org/10.18027/2224-5057-2019-9-3s2-576-584
7. Manzyuk L.V. Modern approaches to systemic drug treatment of bone metastases. Farmateka. 2013; 17(270): 15–19 (In Russian).
8. Sarmanaeva R.R., Abuzarova G.R., Bychkova N.V., et. al. Treatment of variable pain syndrome during radiation therapy of bone metastases of breast cancer. Medical Council. 2019; 19: 165–168 (In Russian). https://doi.org/10.21518/2079-701X-2019-19-165-168
9. Kaprin A.D., Kostin A.A., Vorobyov N.V., et al. Radium-223 for the treatment of patients with castration-resistant prostate cancer with bone metastases. Medical Council. 2018; 10: 78–82 (In Russian). https://doi.org/10.21518/2079-701X-2018-10-78-82
Review
For citations:
Sapaniuk A.I., Ljadov K.V., Polushkin V.G., Alatortsev A.V., Otdelnova O.B. Financial policies in Russian compulsory medical insurance: regional strategies for access to healthcare services in oncology. National Health Care (Russia). 2022;3(2):38-45. (In Russ.) https://doi.org/10.47093/2713-069X.2022.3.2.38-45